Akèy › Tit travay › Senior Validation Engineer
Senior Validation Engineer: Salè H-1B
152 aplikasyon kondisyon travay te itilize tit travay Senior Validation Engineer. Salè baz medyàn ofri $119,240; mwatye mitan $102,741–$133,000.
Demann (LCA)152
Salè medyan ofri$119,240
Mwatye salè yo$102,741–$133,000
10yèm–90yèm pousantaj$93,784–$149,760
Avoka imigrasyon, rekritè oswa anplwayè? Mete sèvis ou an tèt paj sa a — $99 pou 30 jou →
Anplwayè yo
| Anplwayè | LCA | Salè medyan |
|---|
| August Bioservices, LLC | 6 | $112,500 |
| Grand River Aseptic Manufacturing | 6 | $111,072 |
| Verista, Inc. | 5 | $123,123 |
| Astera Labs INC | 4 | $155,102 |
| Trinity Consultants, Inc. | 4 | $129,644 |
| Patel Consultants Corporation | 3 | $135,200 |
| Siemens Mobility, Inc. | 3 | $131,123 |
| Shire Human Genetic Therapies Inc. | 3 | $120,000 |
| Illumina, Inc. | 3 | $98,904 |
| Arranta Bio MA LLC | 3 | $130,000 |
| IPS-Integrated Project Services, LLC | 3 | $97,115 |
| Azzur Group LLC dba Azzur Consulting LLC | 3 | $149,760 |
| PSC Biotech Corporation | 3 | $119,692 |
| ND Global Consulting Services Inc. | 3 | $133,000 |
| Arranta Bio MA2 LLC | 3 | $130,000 |
| NorthStar Medical Radioisotopes, LLC | 3 | $130,000 |
| Beckman Coulter, Inc. | 3 | $107,934 |
| QPharma, Inc. | 2 | $93,784 |
| Validation & Technical Services Integrated Inc | 2 | $102,357 |
| Seagen Inc. | 2 | $135,168 |
| VTS Consultants, Inc. | 2 | $100,000 |
| CSL Behring L.L.C. | 2 | $91,032 |
| Zeco Systems, Inc. | 2 | $123,926 |
| Arm, Inc. | 2 | $121,805 |
| AstraZeneca Pharmaceuticals LP | 2 | $135,982 |
| Microchip Technology Inc. | 2 | $81,319 |
| Celere, Inc. | 2 | $105,851 |
| Pentangle Tech Services LLC | 2 | $117,706 |
| Lonza Houston Inc | 2 | $111,158 |
| Nikola Corporation | 2 | $147,500 |
| ProBio Inc. | 2 | $93,000 |
| Pfizer Inc. | 2 | $87,379 |
| Organogenesis, Inc. | 2 | $104,350 |
| Silicon Laboratories, Inc. | 2 | $171,452 |
| IZiel Healthcare Inc | 2 | $110,000 |
| Compli Group, Inc. | 2 | $144,240 |
| Kforce Inc. | 2 | $98,405 |
| Jsat Automation Inc | 2 | $98,592 |
| Bimeda Pomona Inc. | 2 | $132,000 |
| NITCO Inc | 1 | $103,626 |
| Takeda Pharmaceuticals USA, Inc. | 1 | $105,000 |
| I3 Infotek Inc | 1 | $94,000 |
| Berkshire Sterile Manufacturing, LLC | 1 | $95,000 |
| Intellectt, Inc. | 1 | $101,920 |
| Catalent Pharma Solutions | 1 | $103,000 |
| General Motors | 1 | $116,723 |
| Mallinckrodt Enterprises LLC | 1 | $79,719 |
| Nevro Corp | 1 | $155,958 |
| AmplifyBio, LLC | 1 | $135,000 |
| Alcon Research, LLC | 1 | $86,299 |
| The DiLisi Group Inc. | 1 | — |
| Pharma Tek Solutions, Inc. | 1 | $140,000 |
| Intone Networks, Inc. | 1 | $121,000 |
| ProKidney LLC | 1 | $75,000 |
| Thermo Fisher Scientific Inc. | 1 | $118,789 |
| Valsource, Inc. | 1 | $133,058 |
| AbbVie Bioresearch Center Inc. | 1 | $131,000 |
| GenScript ProBio USA Inc. | 1 | $93,000 |
| Sirius XM Radio Inc. | 1 | $120,000 |
| Nexteer Automotive Corporation | 1 | $113,838 |
Pa nivo salè
| Nivo revni | Salè medyan |
|---|
| Nivo I (antre) | $88,150 |
| Nivo II (kalifye) | $100,700 |
| Nivo III (eksperyans) | $120,000 |
| Nivo IV (plen kompetans) | $131,562 |
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Pa ane fiskal
| Ane fiskal | LCA | Salè medyan |
|---|
| FY2023 | 46 | $115,230 |
| FY2024 | 36 | $114,419 |
| FY2025 | 39 | $118,450 |
| FY2026 | 27 | $122,096 |
Vil yo
- Nashville, TN6
- Watertown, MA6
- Grand Rapids, MI6
- Lexington, MA5
- Homestead, PA3
- Bothell, WA3
- Somerset, NJ3
- Bloomington, IN3
- Los Angeles, CA3
- Beloit, WI3
- Santa Clara, CA3
- Chaska, MN3
- Canton, MA3
- Austin, TX3
- Norwood, MA2
- Morristown, NJ2
- Des Plaines, IL2
- San Diego, CA2
- Lee, MA2
- Melville, NY2
- Waltham, MA2
- Bradley, IL2
- Chandler, AZ2
- Coppell, TX2
- Edison, NJ2
- Durham, NC2
- Houston, TX2
- Phoenix, AZ2
- Pennington, NJ2
- Auburn Hills, MI2
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).